Why is nobody talking about Mettrum I'm surprised there isn't much discussion about MT.
To me they have the most room to grow of the big LPs. Based on yesterday's earnings report they have slightly less than half of the revenues and patients of CGC, but with 1/5th the market cap. They are also the second largest LP in terms of production capacity. AND just acquired a MMJ research firm with ~5000 active patients. All with much fewer shares issued than CGC (47mil vs. CGC's 116mil).
If MT had even half the market cap of CGC their sp would be over $15 ! Even with a more modest market cap of 500mil the share price would be $10.60.
Currently sitting at 7.25 but I think it could be worth 9-10 soon.